1,757
Views
0
CrossRef citations to date
0
Altmetric
Transferred Article

Randomized controlled trial of the effects of consumption of ‘Yabukita’ or ‘Benifuuki’ encapsulated tea-powder on low-density lipoprotein cholesterol level and body weight

, , , , , , , , , & show all
Article: 1334484 | Received 21 Dec 2016, Accepted 18 May 2017, Published online: 19 Jun 2017

References

  • Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138:1548–8.
  • Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296:1255–1265.
  • Tang J, Zheng J, Fang L, et al. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015;114:673–683.
  • Yoshino K, Hara Y, Sano M, et al. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull. 1994;17:146–149.
  • Kobayashi M, Nishizawa M, Inoue N, et al. Epigallocatechin gallate decreases the micellar solubility of cholesterol via specific interaction with phosphatidylcholine. J Agric Food Chem. 2014;62:2881–2890.
  • Nakagawa K, Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol. 1997;43:679–684.
  • Maeda-Yamamoto M. Human clinical studies of tea polyphenols in allergy or life style-related diseases. Curr Pharm Des. 2013;19:6148–6155.
  • Suzuki Y, Nozawa A, Miyamoto S, et al. Reduction of visceral fat in overweight female volunteers by long-term ingestion of tea catechins with a galloyl moiety a randomized double-blind placebo-controlled study. Jpn Pharmacol Ther. 2009;37:521–527.
  • Kajimoto O, Kajimoto Y, Yabune M, et al. Tea catechins with a galloyl moiety reduce body weight and fat. J Health Sci. 2005;51:161–171.
  • Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38–50.
  • Kurita I, Maeda-Yamamoto M, Tachibana H, et al. Antihypertensive effect of Benifuuki tea containing O-methylated EGCG. J Agric Food Chem. 2010;58:1903–1908.
  • Suzuki T, Kumazoe M, Kim Y, et al. Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorder. Sci Rep. 2013;3:2749.
  • Kim A, Chiu A, Barone MK, et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc. 2011;111:1720–1729.
  • Imbe H, Sano H, Miyawaki M, et al. “Benifuuki” green tea, containing O-methylated EGCG, reduces serum low-density lipoprotein cholesterol and lectin-like oxidized low-density lipoprotein receptor-1 ligands low-density lipoprotein receptor-1 ligands containing apolipoprotein B: a double-blind, placebo-controlled randomized trial. J Funct Foods. 2016;25:25–37.
  • Phung OJ, Baker WL, Matthews LJ, et al. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010;91:73–81.
  • Nagao T, Hase T, Tokimitsu I. A green tea extracr high in catechins reduces body fat and cardiovascular risks in humans. Obesity. 2007;15:1473–1483.
  • Auvichayapat P, Prapochanung M, Tunkamnerdthai O, et al. Effectiveness of green tea on weight reduction in obese Thais: a randomized controlled trial. Physiology & Behavior. 2008;93:486–491.
  • Suliburska J, Bogdanski P, Szulinska M, et al. Effects of green tea supplementation on elements, total antioxidants, lipids and glucose values in the serum of obese patients. Biol Trace Elem Res. 2012;149:315–322.
  • Yokozawa T, Nakagawa T, Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem. 2002;50:3549–3552.
  • Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27–32.
  • Feigin L, Forouzanfar H, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;18:245–254.